Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Twins | 44 | 2024 | 52 | 5.430 |
Why?
|
Twins, Monozygotic | 50 | 2025 | 69 | 4.770 |
Why?
|
Aging | 49 | 2025 | 710 | 4.720 |
Why?
|
Twins, Dizygotic | 48 | 2025 | 54 | 4.700 |
Why?
|
Diseases in Twins | 35 | 2025 | 55 | 4.550 |
Why?
|
Cognition | 42 | 2024 | 455 | 4.320 |
Why?
|
Cognitive Dysfunction | 22 | 2024 | 309 | 3.370 |
Why?
|
Gene-Environment Interaction | 19 | 2025 | 48 | 2.940 |
Why?
|
Stress Disorders, Post-Traumatic | 26 | 2024 | 380 | 2.920 |
Why?
|
Phenotype | 52 | 2025 | 1137 | 2.470 |
Why?
|
Alzheimer Disease | 21 | 2024 | 679 | 2.450 |
Why?
|
Neuropsychological Tests | 31 | 2024 | 371 | 2.420 |
Why?
|
Male | 213 | 2025 | 27739 | 2.260 |
Why?
|
Neurodevelopmental Disorders | 9 | 2023 | 34 | 2.050 |
Why?
|
Environment | 25 | 2020 | 119 | 2.010 |
Why?
|
Intellectual Disability | 12 | 2024 | 159 | 1.960 |
Why?
|
Middle Aged | 154 | 2025 | 16317 | 1.920 |
Why?
|
Cognition Disorders | 14 | 2019 | 215 | 1.890 |
Why?
|
Cerebral Cortex | 17 | 2024 | 248 | 1.870 |
Why?
|
Genetic Predisposition to Disease | 30 | 2025 | 676 | 1.860 |
Why?
|
Registries | 31 | 2020 | 801 | 1.840 |
Why?
|
Humans | 248 | 2025 | 59360 | 1.790 |
Why?
|
Longitudinal Studies | 39 | 2025 | 1189 | 1.720 |
Why?
|
Executive Function | 13 | 2024 | 61 | 1.660 |
Why?
|
Magnetic Resonance Imaging | 44 | 2024 | 2060 | 1.640 |
Why?
|
Brain | 33 | 2024 | 1488 | 1.620 |
Why?
|
Memory, Episodic | 11 | 2024 | 18 | 1.570 |
Why?
|
Developmental Disabilities | 7 | 2023 | 108 | 1.540 |
Why?
|
White Matter | 13 | 2024 | 114 | 1.440 |
Why?
|
Chromosome Deletion | 5 | 2023 | 41 | 1.370 |
Why?
|
Erectile Dysfunction | 3 | 2023 | 22 | 1.370 |
Why?
|
Vietnam Conflict | 21 | 2018 | 23 | 1.310 |
Why?
|
Veterans | 34 | 2021 | 728 | 1.250 |
Why?
|
Hypertension | 9 | 2023 | 568 | 1.130 |
Why?
|
Twin Studies as Topic | 12 | 2021 | 14 | 1.050 |
Why?
|
Body Mass Index | 12 | 2019 | 831 | 1.040 |
Why?
|
Adult | 83 | 2024 | 15669 | 1.040 |
Why?
|
Social Environment | 10 | 2012 | 91 | 1.030 |
Why?
|
Depression | 14 | 2022 | 828 | 1.030 |
Why?
|
Mutation | 12 | 2022 | 2456 | 1.000 |
Why?
|
Cardiovascular Diseases | 5 | 2022 | 788 | 0.960 |
Why?
|
Hippocampus | 9 | 2024 | 246 | 0.920 |
Why?
|
Memory, Short-Term | 6 | 2022 | 59 | 0.920 |
Why?
|
Aged | 57 | 2025 | 13416 | 0.900 |
Why?
|
Genetics, Behavioral | 5 | 2013 | 11 | 0.890 |
Why?
|
Metabolic Syndrome | 2 | 2022 | 131 | 0.850 |
Why?
|
Risk Factors | 34 | 2025 | 4984 | 0.830 |
Why?
|
Megalencephaly | 3 | 2022 | 5 | 0.830 |
Why?
|
Genotype | 13 | 2024 | 617 | 0.800 |
Why?
|
Apolipoproteins E | 6 | 2024 | 108 | 0.780 |
Why?
|
Spinal Dysraphism | 1 | 2022 | 16 | 0.770 |
Why?
|
Depressive Disorder, Major | 9 | 2021 | 245 | 0.770 |
Why?
|
Neural Tube Defects | 1 | 2022 | 27 | 0.770 |
Why?
|
Child | 30 | 2024 | 4174 | 0.770 |
Why?
|
Hydrocortisone | 9 | 2018 | 187 | 0.760 |
Why?
|
Sleep | 3 | 2021 | 215 | 0.750 |
Why?
|
Pedigree | 6 | 2021 | 183 | 0.750 |
Why?
|
Biomarkers | 9 | 2024 | 1306 | 0.750 |
Why?
|
Genome-Wide Association Study | 11 | 2024 | 331 | 0.730 |
Why?
|
Combat Disorders | 6 | 2013 | 10 | 0.710 |
Why?
|
Circadian Rhythm | 6 | 2014 | 373 | 0.710 |
Why?
|
DEAD-box RNA Helicases | 1 | 2021 | 79 | 0.700 |
Why?
|
Hypercholesterolemia | 1 | 2021 | 68 | 0.690 |
Why?
|
Body Height | 5 | 2020 | 68 | 0.690 |
Why?
|
Sleep Apnea Syndromes | 1 | 2021 | 26 | 0.690 |
Why?
|
Young Adult | 29 | 2023 | 4267 | 0.680 |
Why?
|
Female | 65 | 2024 | 30705 | 0.680 |
Why?
|
Alcoholism | 8 | 2008 | 309 | 0.650 |
Why?
|
Mutation, Missense | 6 | 2024 | 172 | 0.640 |
Why?
|
Locus Coeruleus | 5 | 2024 | 21 | 0.630 |
Why?
|
Child, Preschool | 17 | 2023 | 1782 | 0.630 |
Why?
|
Aptitude | 3 | 2019 | 10 | 0.630 |
Why?
|
Quantitative Trait, Heritable | 8 | 2020 | 26 | 0.620 |
Why?
|
Abnormalities, Multiple | 3 | 2016 | 51 | 0.620 |
Why?
|
Individuality | 3 | 2017 | 21 | 0.610 |
Why?
|
Autism Spectrum Disorder | 2 | 2021 | 175 | 0.610 |
Why?
|
Testosterone | 5 | 2020 | 112 | 0.600 |
Why?
|
Infant | 14 | 2023 | 1486 | 0.590 |
Why?
|
Age Factors | 13 | 2025 | 1504 | 0.580 |
Why?
|
Meningomyelocele | 1 | 2017 | 11 | 0.580 |
Why?
|
Panic Disorder | 2 | 2011 | 31 | 0.580 |
Why?
|
Models, Genetic | 12 | 2019 | 255 | 0.580 |
Why?
|
Genes, Dominant | 2 | 2021 | 55 | 0.580 |
Why?
|
Reaction Time | 4 | 2019 | 119 | 0.570 |
Why?
|
Cognitive Reserve | 4 | 2024 | 8 | 0.560 |
Why?
|
Amyloid beta-Peptides | 6 | 2024 | 286 | 0.560 |
Why?
|
Statistics as Topic | 4 | 2013 | 146 | 0.550 |
Why?
|
Genetic Variation | 8 | 2024 | 357 | 0.540 |
Why?
|
tau Proteins | 5 | 2024 | 191 | 0.540 |
Why?
|
Arousal | 3 | 2015 | 41 | 0.540 |
Why?
|
Dwarfism | 1 | 2016 | 12 | 0.530 |
Why?
|
Neurofilament Proteins | 3 | 2024 | 20 | 0.520 |
Why?
|
Cognitive Aging | 3 | 2022 | 4 | 0.510 |
Why?
|
Neurodegenerative Diseases | 3 | 2024 | 134 | 0.500 |
Why?
|
Parents | 3 | 2020 | 367 | 0.500 |
Why?
|
Adolescent | 29 | 2023 | 5824 | 0.500 |
Why?
|
Chromosomes, Human, Pair 17 | 3 | 2014 | 23 | 0.500 |
Why?
|
Antisocial Personality Disorder | 6 | 2019 | 34 | 0.500 |
Why?
|
Smoking | 8 | 2022 | 826 | 0.480 |
Why?
|
Surveys and Questionnaires | 11 | 2021 | 2513 | 0.480 |
Why?
|
Vietnam | 13 | 2022 | 165 | 0.480 |
Why?
|
Calcium-Transporting ATPases | 1 | 2014 | 7 | 0.470 |
Why?
|
Diffusion Tensor Imaging | 7 | 2022 | 69 | 0.470 |
Why?
|
Chromosome Duplication | 1 | 2014 | 3 | 0.470 |
Why?
|
Brain Mapping | 10 | 2018 | 228 | 0.470 |
Why?
|
Spirituality | 2 | 2007 | 37 | 0.470 |
Why?
|
Chromosomes, Human, Pair 16 | 1 | 2014 | 25 | 0.470 |
Why?
|
Tobacco Use Disorder | 7 | 2015 | 243 | 0.460 |
Why?
|
Alcohol Drinking | 9 | 2022 | 288 | 0.460 |
Why?
|
Language Disorders | 1 | 2014 | 24 | 0.460 |
Why?
|
Organ Size | 13 | 2024 | 164 | 0.460 |
Why?
|
Leukoencephalopathies | 3 | 2021 | 24 | 0.450 |
Why?
|
Blepharophimosis | 1 | 2014 | 2 | 0.450 |
Why?
|
DNA-Binding Proteins | 2 | 2020 | 1151 | 0.450 |
Why?
|
Chromosomes, Human, Pair 3 | 1 | 2014 | 12 | 0.450 |
Why?
|
Skin Abnormalities | 1 | 2014 | 8 | 0.450 |
Why?
|
Microcephaly | 1 | 2014 | 12 | 0.450 |
Why?
|
Apolipoprotein E4 | 5 | 2022 | 44 | 0.450 |
Why?
|
Independent Living | 3 | 2024 | 44 | 0.440 |
Why?
|
Early Diagnosis | 6 | 2020 | 92 | 0.440 |
Why?
|
Life Change Events | 4 | 2018 | 65 | 0.440 |
Why?
|
Mental Recall | 6 | 2021 | 88 | 0.430 |
Why?
|
Alleles | 6 | 2019 | 411 | 0.420 |
Why?
|
Genetic Association Studies | 7 | 2019 | 113 | 0.420 |
Why?
|
Cohort Studies | 19 | 2023 | 2374 | 0.420 |
Why?
|
Semantics | 2 | 2020 | 57 | 0.410 |
Why?
|
Mental Disorders | 10 | 2020 | 717 | 0.400 |
Why?
|
Verbal Learning | 3 | 2013 | 20 | 0.400 |
Why?
|
Chromosomes, Human, Y | 1 | 2012 | 5 | 0.400 |
Why?
|
Chromosome Disorders | 1 | 2012 | 14 | 0.400 |
Why?
|
Comorbidity | 16 | 2016 | 1078 | 0.390 |
Why?
|
Trisomy | 1 | 2012 | 19 | 0.390 |
Why?
|
Translocation, Genetic | 1 | 2012 | 63 | 0.390 |
Why?
|
Language Development Disorders | 2 | 2022 | 26 | 0.390 |
Why?
|
Genes, Duplicate | 1 | 2011 | 1 | 0.390 |
Why?
|
Classical Lissencephalies and Subcortical Band Heterotopias | 1 | 2011 | 1 | 0.390 |
Why?
|
1-Alkyl-2-acetylglycerophosphocholine Esterase | 1 | 2011 | 2 | 0.390 |
Why?
|
Chronic Pain | 2 | 2024 | 134 | 0.390 |
Why?
|
United States | 25 | 2025 | 7390 | 0.370 |
Why?
|
Feedback, Psychological | 1 | 2011 | 11 | 0.370 |
Why?
|
Space Perception | 1 | 2011 | 19 | 0.370 |
Why?
|
Microtubule-Associated Proteins | 1 | 2011 | 111 | 0.360 |
Why?
|
Verbal Behavior | 3 | 2020 | 36 | 0.350 |
Why?
|
Myotonia Congenita | 1 | 2010 | 1 | 0.350 |
Why?
|
Carbamazepine | 1 | 2010 | 11 | 0.350 |
Why?
|
Gastrointestinal Diseases | 1 | 2011 | 69 | 0.340 |
Why?
|
Psychiatric Status Rating Scales | 11 | 2011 | 379 | 0.340 |
Why?
|
Chloride Channels | 1 | 2010 | 28 | 0.340 |
Why?
|
DNA Copy Number Variations | 3 | 2022 | 65 | 0.340 |
Why?
|
Transcription Factors | 2 | 2022 | 1471 | 0.330 |
Why?
|
Urogenital Abnormalities | 2 | 2023 | 10 | 0.330 |
Why?
|
Neuroimaging | 4 | 2024 | 143 | 0.330 |
Why?
|
Microarray Analysis | 3 | 2014 | 60 | 0.320 |
Why?
|
DNA Methylation | 2 | 2022 | 271 | 0.310 |
Why?
|
Health Status | 4 | 2012 | 424 | 0.310 |
Why?
|
Disease Progression | 9 | 2021 | 1122 | 0.310 |
Why?
|
Body Weight | 3 | 2017 | 368 | 0.300 |
Why?
|
Blood Pressure | 5 | 2023 | 495 | 0.290 |
Why?
|
Memory | 5 | 2021 | 111 | 0.290 |
Why?
|
Models, Psychological | 7 | 2011 | 94 | 0.290 |
Why?
|
alpha-Mannosidosis | 1 | 2007 | 1 | 0.290 |
Why?
|
Nicotine | 3 | 2005 | 113 | 0.290 |
Why?
|
Zebrafish | 4 | 2024 | 326 | 0.290 |
Why?
|
Gray Matter | 3 | 2024 | 31 | 0.290 |
Why?
|
Haploinsufficiency | 3 | 2023 | 15 | 0.290 |
Why?
|
Infant, Newborn | 4 | 2021 | 1283 | 0.290 |
Why?
|
Smoking Cessation | 6 | 2022 | 541 | 0.280 |
Why?
|
Nerve Tissue Proteins | 2 | 2021 | 418 | 0.280 |
Why?
|
Nerve Net | 2 | 2019 | 93 | 0.280 |
Why?
|
Models, Statistical | 9 | 2021 | 298 | 0.280 |
Why?
|
Pupil | 2 | 2017 | 9 | 0.280 |
Why?
|
Family Health | 2 | 2008 | 67 | 0.280 |
Why?
|
Pattern Recognition, Visual | 1 | 2007 | 37 | 0.280 |
Why?
|
Saliva | 9 | 2018 | 99 | 0.280 |
Why?
|
Chromosomes, Human, X | 3 | 2012 | 35 | 0.270 |
Why?
|
Time Factors | 10 | 2015 | 3617 | 0.270 |
Why?
|
Ganglionic Stimulants | 2 | 2005 | 6 | 0.270 |
Why?
|
Behavior | 2 | 2021 | 36 | 0.260 |
Why?
|
C-Reactive Protein | 2 | 2024 | 159 | 0.250 |
Why?
|
Language | 2 | 2019 | 133 | 0.250 |
Why?
|
Dyslexia | 1 | 2005 | 8 | 0.250 |
Why?
|
Environmental Exposure | 4 | 2023 | 208 | 0.250 |
Why?
|
Presbycusis | 1 | 2025 | 6 | 0.240 |
Why?
|
Educational Measurement | 1 | 2007 | 211 | 0.240 |
Why?
|
Prevalence | 13 | 2017 | 1252 | 0.240 |
Why?
|
Overweight | 1 | 2007 | 238 | 0.240 |
Why?
|
Hearing | 1 | 2025 | 30 | 0.240 |
Why?
|
Parent-Child Relations | 1 | 2005 | 57 | 0.240 |
Why?
|
Educational Status | 5 | 2022 | 264 | 0.240 |
Why?
|
Family | 3 | 2020 | 229 | 0.240 |
Why?
|
Galvanic Skin Response | 1 | 2004 | 23 | 0.230 |
Why?
|
Attention Deficit Disorder with Hyperactivity | 1 | 2006 | 156 | 0.230 |
Why?
|
Polymorphism, Single Nucleotide | 6 | 2024 | 439 | 0.230 |
Why?
|
Schizophrenia | 2 | 2006 | 242 | 0.230 |
Why?
|
Coitus | 1 | 2004 | 15 | 0.230 |
Why?
|
Education | 2 | 2019 | 68 | 0.220 |
Why?
|
Exome | 3 | 2022 | 73 | 0.220 |
Why?
|
Agoraphobia | 1 | 2004 | 11 | 0.220 |
Why?
|
Homosexuality, Male | 1 | 2004 | 38 | 0.220 |
Why?
|
Dementia | 3 | 2023 | 248 | 0.220 |
Why?
|
California | 3 | 2013 | 159 | 0.220 |
Why?
|
Vesico-Ureteral Reflux | 1 | 2023 | 12 | 0.220 |
Why?
|
Risk | 7 | 2019 | 364 | 0.220 |
Why?
|
Obesity | 3 | 2019 | 1166 | 0.220 |
Why?
|
Severity of Illness Index | 6 | 2015 | 1479 | 0.220 |
Why?
|
Sexual Partners | 1 | 2004 | 75 | 0.220 |
Why?
|
Genetic Loci | 2 | 2024 | 107 | 0.210 |
Why?
|
Kidney Diseases, Cystic | 1 | 2023 | 20 | 0.210 |
Why?
|
Cerebellum | 1 | 2024 | 91 | 0.210 |
Why?
|
Myocardial Ischemia | 2 | 2017 | 111 | 0.210 |
Why?
|
Positron-Emission Tomography | 1 | 2024 | 200 | 0.210 |
Why?
|
Forced Expiratory Volume | 2 | 2014 | 193 | 0.210 |
Why?
|
Life Style | 3 | 2021 | 299 | 0.210 |
Why?
|
Aged, 80 and over | 8 | 2021 | 5128 | 0.210 |
Why?
|
Heroin Dependence | 3 | 2008 | 22 | 0.210 |
Why?
|
Cutis Laxa | 1 | 2023 | 6 | 0.210 |
Why?
|
Gene Regulatory Networks | 1 | 2024 | 147 | 0.210 |
Why?
|
Intermediate Filaments | 1 | 2022 | 10 | 0.210 |
Why?
|
RNA Splicing | 2 | 2021 | 159 | 0.210 |
Why?
|
Analysis of Variance | 5 | 2014 | 589 | 0.210 |
Why?
|
Nervous System Malformations | 1 | 2022 | 12 | 0.210 |
Why?
|
Image Processing, Computer-Assisted | 9 | 2018 | 654 | 0.210 |
Why?
|
Air Pollution | 1 | 2023 | 29 | 0.200 |
Why?
|
Retinal Dystrophies | 1 | 2022 | 4 | 0.200 |
Why?
|
Zebrafish Proteins | 2 | 2020 | 151 | 0.200 |
Why?
|
Conduct Disorder | 3 | 2007 | 24 | 0.200 |
Why?
|
Retinitis Pigmentosa | 1 | 2022 | 28 | 0.200 |
Why?
|
Loeys-Dietz Syndrome | 1 | 2022 | 4 | 0.200 |
Why?
|
Connective Tissue Diseases | 1 | 2022 | 10 | 0.200 |
Why?
|
Inheritance Patterns | 5 | 2018 | 18 | 0.200 |
Why?
|
Tauopathies | 1 | 2022 | 18 | 0.190 |
Why?
|
Air Pollutants | 1 | 2023 | 76 | 0.190 |
Why?
|
SOXB1 Transcription Factors | 1 | 2022 | 20 | 0.190 |
Why?
|
Amino Acids | 1 | 2023 | 140 | 0.190 |
Why?
|
Encephalocele | 1 | 2022 | 15 | 0.190 |
Why?
|
Kidney Diseases | 1 | 2023 | 169 | 0.190 |
Why?
|
Health Surveys | 4 | 2013 | 298 | 0.190 |
Why?
|
Frailty | 1 | 2024 | 124 | 0.190 |
Why?
|
Academic Success | 2 | 2020 | 11 | 0.190 |
Why?
|
Interpersonal Relations | 3 | 2018 | 150 | 0.190 |
Why?
|
Genes | 2 | 2012 | 90 | 0.190 |
Why?
|
Anisotropy | 5 | 2019 | 58 | 0.190 |
Why?
|
Epilepsy, Generalized | 1 | 2021 | 4 | 0.190 |
Why?
|
Substance-Related Disorders | 6 | 2010 | 682 | 0.190 |
Why?
|
Sickness Impact Profile | 2 | 2015 | 47 | 0.190 |
Why?
|
Healthy Lifestyle | 1 | 2021 | 27 | 0.180 |
Why?
|
Down Syndrome | 1 | 2022 | 47 | 0.180 |
Why?
|
Niemann-Pick Disease, Type C | 1 | 2021 | 1 | 0.180 |
Why?
|
Self Report | 2 | 2021 | 359 | 0.180 |
Why?
|
Regression Analysis | 3 | 2013 | 485 | 0.180 |
Why?
|
Diagnostic and Statistical Manual of Mental Disorders | 5 | 2007 | 116 | 0.180 |
Why?
|
Epilepsy | 2 | 2021 | 105 | 0.180 |
Why?
|
Infratentorial Neoplasms | 1 | 2021 | 4 | 0.180 |
Why?
|
Rhabdoid Tumor | 1 | 2021 | 3 | 0.180 |
Why?
|
Photic Stimulation | 2 | 2014 | 89 | 0.180 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 1 | 2021 | 124 | 0.180 |
Why?
|
Transcriptome | 1 | 2024 | 340 | 0.180 |
Why?
|
Cigarette Smoking | 1 | 2021 | 53 | 0.180 |
Why?
|
Multivariate Analysis | 5 | 2014 | 902 | 0.180 |
Why?
|
Genomic Instability | 1 | 2021 | 53 | 0.180 |
Why?
|
Marijuana Abuse | 4 | 2005 | 20 | 0.180 |
Why?
|
RNA, Double-Stranded | 1 | 2021 | 106 | 0.180 |
Why?
|
Mental Retardation, X-Linked | 1 | 2020 | 3 | 0.180 |
Why?
|
Sarcoma | 1 | 2021 | 37 | 0.180 |
Why?
|
Neoplasms, Second Primary | 1 | 2021 | 43 | 0.180 |
Why?
|
Atherosclerosis | 1 | 2022 | 146 | 0.180 |
Why?
|
Receptors, Androgen | 1 | 2020 | 27 | 0.180 |
Why?
|
Seizures | 1 | 2021 | 113 | 0.170 |
Why?
|
Genetic Background | 1 | 2020 | 5 | 0.170 |
Why?
|
Heterozygote | 3 | 2019 | 161 | 0.170 |
Why?
|
Recurrence | 1 | 2022 | 603 | 0.170 |
Why?
|
Genetic Testing | 2 | 2018 | 126 | 0.170 |
Why?
|
Spliceosomes | 1 | 2020 | 41 | 0.170 |
Why?
|
Prospective Studies | 4 | 2021 | 3067 | 0.170 |
Why?
|
Memory Disorders | 3 | 2023 | 48 | 0.170 |
Why?
|
Neurofibromin 1 | 1 | 2019 | 11 | 0.170 |
Why?
|
Amino Acid Substitution | 2 | 2019 | 234 | 0.160 |
Why?
|
Protein Tyrosine Phosphatases, Non-Receptor | 1 | 2019 | 5 | 0.160 |
Why?
|
Prefrontal Cortex | 2 | 2010 | 107 | 0.160 |
Why?
|
Kidney Neoplasms | 1 | 2021 | 126 | 0.160 |
Why?
|
Personal Satisfaction | 2 | 2012 | 76 | 0.160 |
Why?
|
Parenting | 1 | 2020 | 67 | 0.160 |
Why?
|
Neurofibromatosis 1 | 1 | 2019 | 28 | 0.160 |
Why?
|
DNA Helicases | 1 | 2021 | 187 | 0.160 |
Why?
|
Diabetes Mellitus | 2 | 2017 | 515 | 0.160 |
Why?
|
Cross-Sectional Studies | 8 | 2024 | 2373 | 0.160 |
Why?
|
Facies | 2 | 2016 | 7 | 0.160 |
Why?
|
Rest | 1 | 2019 | 44 | 0.160 |
Why?
|
Spasms, Infantile | 1 | 2018 | 1 | 0.160 |
Why?
|
Calcium Channels, R-Type | 1 | 2018 | 2 | 0.160 |
Why?
|
Social Class | 4 | 2018 | 122 | 0.160 |
Why?
|
Contracture | 1 | 2018 | 8 | 0.160 |
Why?
|
Dyskinesias | 1 | 2018 | 9 | 0.150 |
Why?
|
Emotions | 2 | 2011 | 214 | 0.150 |
Why?
|
Cation Transport Proteins | 1 | 2018 | 19 | 0.150 |
Why?
|
Antihypertensive Agents | 3 | 2015 | 162 | 0.150 |
Why?
|
Thrombocytopenia | 1 | 2018 | 45 | 0.150 |
Why?
|
Comparative Genomic Hybridization | 2 | 2015 | 20 | 0.150 |
Why?
|
Coronary Disease | 1 | 2019 | 244 | 0.150 |
Why?
|
Peptide Fragments | 3 | 2024 | 400 | 0.140 |
Why?
|
Sex Factors | 5 | 2019 | 935 | 0.140 |
Why?
|
Ubiquitin-Protein Ligases | 1 | 2019 | 210 | 0.140 |
Why?
|
Exons | 1 | 2018 | 191 | 0.140 |
Why?
|
Personality Inventory | 3 | 2012 | 54 | 0.140 |
Why?
|
Human Development | 1 | 2017 | 9 | 0.140 |
Why?
|
Genetic Linkage | 2 | 2008 | 93 | 0.140 |
Why?
|
Brain Neoplasms | 1 | 2021 | 305 | 0.140 |
Why?
|
Homeodomain Proteins | 1 | 2019 | 255 | 0.140 |
Why?
|
Histones | 1 | 2020 | 458 | 0.140 |
Why?
|
GTPase-Activating Proteins | 1 | 2017 | 64 | 0.140 |
Why?
|
RNA-Binding Proteins | 1 | 2020 | 386 | 0.140 |
Why?
|
Dyslipidemias | 1 | 2017 | 33 | 0.140 |
Why?
|
Actins | 1 | 2018 | 259 | 0.140 |
Why?
|
Mental Health | 2 | 2012 | 335 | 0.140 |
Why?
|
Case-Control Studies | 4 | 2014 | 1051 | 0.140 |
Why?
|
Brain Injuries, Traumatic | 1 | 2018 | 84 | 0.130 |
Why?
|
Corpus Callosum | 1 | 2016 | 40 | 0.130 |
Why?
|
Nerve Fibers, Myelinated | 2 | 2018 | 30 | 0.130 |
Why?
|
Models, Neurological | 1 | 2017 | 79 | 0.130 |
Why?
|
Functional Laterality | 2 | 2013 | 133 | 0.130 |
Why?
|
Skin Neoplasms | 1 | 2021 | 404 | 0.130 |
Why?
|
Databases, Factual | 3 | 2015 | 813 | 0.130 |
Why?
|
Retrospective Studies | 7 | 2023 | 6071 | 0.120 |
Why?
|
Intelligence | 1 | 2016 | 55 | 0.120 |
Why?
|
Gene Expression Regulation, Developmental | 3 | 2020 | 619 | 0.120 |
Why?
|
Ulna | 1 | 2015 | 4 | 0.120 |
Why?
|
Inhibitor of Differentiation Proteins | 1 | 2015 | 5 | 0.120 |
Why?
|
Chromosomes, Human, Pair 6 | 1 | 2015 | 17 | 0.120 |
Why?
|
Fibula | 1 | 2015 | 9 | 0.120 |
Why?
|
Radius | 1 | 2015 | 13 | 0.120 |
Why?
|
Osteochondrodysplasias | 1 | 2015 | 11 | 0.120 |
Why?
|
Anthropometry | 1 | 2015 | 78 | 0.120 |
Why?
|
Chromosome Aberrations | 1 | 2015 | 62 | 0.120 |
Why?
|
Risk Assessment | 3 | 2014 | 1921 | 0.120 |
Why?
|
Leg | 1 | 2015 | 85 | 0.120 |
Why?
|
Sequence Deletion | 1 | 2015 | 112 | 0.120 |
Why?
|
Quality of Life | 5 | 2020 | 1137 | 0.120 |
Why?
|
Forced Expiratory Flow Rates | 1 | 2014 | 3 | 0.120 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2016 | 263 | 0.120 |
Why?
|
Tibia | 1 | 2015 | 69 | 0.120 |
Why?
|
Boston | 1 | 2015 | 246 | 0.120 |
Why?
|
Respiration Disorders | 1 | 2014 | 23 | 0.120 |
Why?
|
Age of Onset | 3 | 2021 | 170 | 0.120 |
Why?
|
Language Tests | 1 | 2014 | 39 | 0.120 |
Why?
|
Attention | 3 | 2017 | 146 | 0.120 |
Why?
|
Depressive Disorder | 2 | 2010 | 279 | 0.110 |
Why?
|
Morphogenesis | 1 | 2014 | 108 | 0.110 |
Why?
|
Diffusion Magnetic Resonance Imaging | 3 | 2022 | 145 | 0.110 |
Why?
|
Class I Phosphatidylinositol 3-Kinases | 1 | 2014 | 10 | 0.110 |
Why?
|
Mental Competency | 1 | 2014 | 55 | 0.110 |
Why?
|
Object Attachment | 1 | 2014 | 18 | 0.110 |
Why?
|
Syndrome | 3 | 2022 | 170 | 0.110 |
Why?
|
Cerebrum | 1 | 2013 | 16 | 0.110 |
Why?
|
Principal Component Analysis | 2 | 2018 | 56 | 0.110 |
Why?
|
Cocaine-Related Disorders | 2 | 2005 | 82 | 0.110 |
Why?
|
Radiography | 2 | 2013 | 517 | 0.110 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2014 | 152 | 0.110 |
Why?
|
Genetic Phenomena | 1 | 2013 | 1 | 0.110 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2014 | 170 | 0.110 |
Why?
|
Carrier Proteins | 1 | 2017 | 697 | 0.100 |
Why?
|
Gulf War | 3 | 2009 | 5 | 0.100 |
Why?
|
Vital Capacity | 1 | 2013 | 105 | 0.100 |
Why?
|
Adiposity | 3 | 2019 | 74 | 0.100 |
Why?
|
Chromosomes, Human, Pair 9 | 1 | 2012 | 10 | 0.100 |
Why?
|
Substance Withdrawal Syndrome | 2 | 2005 | 119 | 0.100 |
Why?
|
Sex Chromosomes | 1 | 2012 | 8 | 0.100 |
Why?
|
Vulnerable Populations | 1 | 2013 | 84 | 0.100 |
Why?
|
Chronic Disease | 1 | 2015 | 716 | 0.100 |
Why?
|
Autistic Disorder | 2 | 2012 | 145 | 0.100 |
Why?
|
Research Design | 3 | 2015 | 555 | 0.100 |
Why?
|
Tomography Scanners, X-Ray Computed | 1 | 2011 | 13 | 0.100 |
Why?
|
Sleep Wake Disorders | 1 | 2013 | 65 | 0.100 |
Why?
|
Signal Detection, Psychological | 1 | 2011 | 2 | 0.100 |
Why?
|
Chromosomes, Human, Pair 22 | 1 | 2011 | 10 | 0.090 |
Why?
|
Self Concept | 1 | 2012 | 105 | 0.090 |
Why?
|
Data Interpretation, Statistical | 2 | 2010 | 191 | 0.090 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2012 | 294 | 0.090 |
Why?
|
Dehydroepiandrosterone Sulfate | 1 | 2011 | 13 | 0.090 |
Why?
|
Gene Duplication | 1 | 2011 | 31 | 0.090 |
Why?
|
Facial Expression | 1 | 2010 | 16 | 0.090 |
Why?
|
Follow-Up Studies | 2 | 2018 | 2337 | 0.090 |
Why?
|
Wounds and Injuries | 2 | 2005 | 229 | 0.090 |
Why?
|
Cues | 1 | 2011 | 73 | 0.090 |
Why?
|
Cultural Characteristics | 1 | 2010 | 35 | 0.090 |
Why?
|
Water | 2 | 2022 | 300 | 0.090 |
Why?
|
Amygdala | 2 | 2021 | 78 | 0.090 |
Why?
|
Kidney | 2 | 2023 | 416 | 0.090 |
Why?
|
Dominance-Subordination | 1 | 2010 | 2 | 0.090 |
Why?
|
Frontal Lobe | 1 | 2011 | 64 | 0.090 |
Why?
|
Spouses | 2 | 2011 | 38 | 0.090 |
Why?
|
Logistic Models | 6 | 2017 | 1232 | 0.090 |
Why?
|
Genome | 2 | 2022 | 257 | 0.090 |
Why?
|
Jet Lag Syndrome | 1 | 2010 | 4 | 0.090 |
Why?
|
Cerebral Ventricles | 1 | 2010 | 30 | 0.080 |
Why?
|
Genes, Recessive | 1 | 2010 | 49 | 0.080 |
Why?
|
Confidence Intervals | 2 | 2007 | 241 | 0.080 |
Why?
|
Weight Gain | 1 | 2011 | 163 | 0.080 |
Why?
|
Brain Diseases | 1 | 2011 | 71 | 0.080 |
Why?
|
Travel | 1 | 2010 | 37 | 0.080 |
Why?
|
Mediator Complex | 1 | 2009 | 13 | 0.080 |
Why?
|
Genetic Diseases, X-Linked | 1 | 2009 | 9 | 0.080 |
Why?
|
Causality | 2 | 2006 | 57 | 0.080 |
Why?
|
Germ-Line Mutation | 2 | 2020 | 43 | 0.080 |
Why?
|
Mental Processes | 1 | 2009 | 18 | 0.080 |
Why?
|
Animals | 7 | 2024 | 19651 | 0.080 |
Why?
|
Linear Models | 3 | 2015 | 402 | 0.080 |
Why?
|
Video Games | 1 | 2008 | 12 | 0.080 |
Why?
|
North America | 2 | 2020 | 106 | 0.080 |
Why?
|
Australia | 2 | 2020 | 86 | 0.080 |
Why?
|
Problem Solving | 1 | 2008 | 30 | 0.080 |
Why?
|
Europe | 2 | 2020 | 184 | 0.080 |
Why?
|
Self Disclosure | 1 | 2008 | 37 | 0.080 |
Why?
|
Algorithms | 1 | 2014 | 976 | 0.080 |
Why?
|
Military Personnel | 3 | 2005 | 97 | 0.070 |
Why?
|
Anxiety Disorders | 1 | 2010 | 186 | 0.070 |
Why?
|
Genetic Markers | 1 | 2008 | 116 | 0.070 |
Why?
|
Factor Analysis, Statistical | 3 | 2018 | 98 | 0.070 |
Why?
|
Muscle Hypotonia | 1 | 2007 | 6 | 0.070 |
Why?
|
Basal Ganglia Diseases | 1 | 2007 | 5 | 0.070 |
Why?
|
Existentialism | 1 | 2007 | 1 | 0.070 |
Why?
|
Contrast Sensitivity | 1 | 2007 | 2 | 0.070 |
Why?
|
Environmental Health | 1 | 2007 | 14 | 0.070 |
Why?
|
North Carolina | 1 | 2007 | 68 | 0.070 |
Why?
|
Proof of Concept Study | 2 | 2018 | 35 | 0.070 |
Why?
|
Odds Ratio | 3 | 2004 | 745 | 0.070 |
Why?
|
Religion and Medicine | 1 | 2007 | 17 | 0.070 |
Why?
|
Receptors, Opioid, mu | 1 | 2007 | 14 | 0.070 |
Why?
|
Chromosome Mapping | 1 | 2008 | 284 | 0.070 |
Why?
|
Warfare | 2 | 2005 | 33 | 0.070 |
Why?
|
Anxiety | 2 | 2021 | 387 | 0.070 |
Why?
|
Atrophy | 2 | 2019 | 76 | 0.070 |
Why?
|
Pituitary-Adrenal System | 3 | 2011 | 60 | 0.070 |
Why?
|
Trail Making Test | 2 | 2019 | 5 | 0.070 |
Why?
|
Reading | 1 | 2007 | 92 | 0.070 |
Why?
|
Neurons | 1 | 2012 | 863 | 0.060 |
Why?
|
Hypothalamo-Hypophyseal System | 3 | 2011 | 88 | 0.060 |
Why?
|
Stress, Psychological | 3 | 2018 | 442 | 0.060 |
Why?
|
Persian Gulf Syndrome | 1 | 2005 | 2 | 0.060 |
Why?
|
Forecasting | 2 | 2018 | 219 | 0.060 |
Why?
|
Psychometrics | 1 | 2007 | 362 | 0.060 |
Why?
|
Audiometry, Pure-Tone | 1 | 2025 | 26 | 0.060 |
Why?
|
Auditory Threshold | 1 | 2025 | 26 | 0.060 |
Why?
|
Herpesvirus 6, Human | 1 | 2005 | 16 | 0.060 |
Why?
|
Habituation, Psychophysiologic | 1 | 2004 | 4 | 0.060 |
Why?
|
Polymorphism, Genetic | 2 | 2020 | 185 | 0.060 |
Why?
|
Genome, Human | 1 | 2006 | 224 | 0.060 |
Why?
|
Intelligence Tests | 2 | 2014 | 25 | 0.060 |
Why?
|
Loss of Function Mutation | 1 | 2024 | 19 | 0.060 |
Why?
|
Tissue Plasminogen Activator | 1 | 2005 | 125 | 0.060 |
Why?
|
Hepatocyte Nuclear Factor 1-beta | 1 | 2023 | 6 | 0.050 |
Why?
|
Protein Phosphatase 2C | 1 | 2023 | 3 | 0.050 |
Why?
|
Protective Factors | 1 | 2023 | 33 | 0.050 |
Why?
|
Orgasm | 1 | 2023 | 1 | 0.050 |
Why?
|
Penile Erection | 1 | 2023 | 3 | 0.050 |
Why?
|
Amphetamine-Related Disorders | 1 | 2003 | 12 | 0.050 |
Why?
|
Multicenter Studies as Topic | 1 | 2023 | 130 | 0.050 |
Why?
|
Ornithine | 1 | 2023 | 22 | 0.050 |
Why?
|
Nitrogen Dioxide | 1 | 2023 | 8 | 0.050 |
Why?
|
Histone Demethylases | 1 | 2022 | 10 | 0.050 |
Why?
|
Janus Kinases | 1 | 2022 | 17 | 0.050 |
Why?
|
Proportional Hazards Models | 1 | 2004 | 674 | 0.050 |
Why?
|
STAT Transcription Factors | 1 | 2022 | 17 | 0.050 |
Why?
|
Proline | 1 | 2023 | 42 | 0.050 |
Why?
|
Face | 1 | 2022 | 33 | 0.050 |
Why?
|
South Carolina | 1 | 2022 | 13 | 0.050 |
Why?
|
Usher Syndromes | 1 | 2022 | 4 | 0.050 |
Why?
|
Computational Biology | 2 | 2019 | 333 | 0.050 |
Why?
|
Central Nervous System Stimulants | 1 | 2003 | 63 | 0.050 |
Why?
|
Creatinine | 1 | 2022 | 128 | 0.050 |
Why?
|
Glutamic Acid | 1 | 2023 | 95 | 0.050 |
Why?
|
Particulate Matter | 1 | 2023 | 52 | 0.050 |
Why?
|
Review Literature as Topic | 1 | 2022 | 33 | 0.050 |
Why?
|
ATP-Binding Cassette Transporters | 1 | 2022 | 36 | 0.050 |
Why?
|
Transforming Growth Factor beta2 | 1 | 2022 | 7 | 0.050 |
Why?
|
Personality Disorders | 1 | 2002 | 19 | 0.050 |
Why?
|
Multiple Sclerosis | 1 | 2005 | 207 | 0.050 |
Why?
|
Vomiting | 1 | 2023 | 133 | 0.050 |
Why?
|
Siblings | 2 | 2015 | 41 | 0.050 |
Why?
|
Norepinephrine | 1 | 2022 | 98 | 0.050 |
Why?
|
Biometry | 2 | 2015 | 11 | 0.050 |
Why?
|
Molecular Chaperones | 1 | 2022 | 99 | 0.050 |
Why?
|
Exercise | 1 | 2009 | 883 | 0.050 |
Why?
|
Antigens, Neoplasm | 1 | 2022 | 133 | 0.050 |
Why?
|
Random Allocation | 1 | 2002 | 192 | 0.050 |
Why?
|
Epilepsies, Myoclonic | 1 | 2021 | 2 | 0.050 |
Why?
|
Status Epilepticus | 1 | 2021 | 21 | 0.050 |
Why?
|
SMARCB1 Protein | 1 | 2021 | 10 | 0.050 |
Why?
|
Cytoskeletal Proteins | 1 | 2022 | 196 | 0.050 |
Why?
|
Mendelian Randomization Analysis | 1 | 2021 | 11 | 0.050 |
Why?
|
Antioxidants | 1 | 2023 | 241 | 0.050 |
Why?
|
Mice | 3 | 2022 | 10292 | 0.040 |
Why?
|
Gene Expression Profiling | 1 | 2024 | 718 | 0.040 |
Why?
|
Heart Diseases | 1 | 2003 | 206 | 0.040 |
Why?
|
Chromosome Structures | 1 | 2020 | 7 | 0.040 |
Why?
|
Trinucleotide Repeats | 1 | 2020 | 17 | 0.040 |
Why?
|
Metabolomics | 1 | 2021 | 49 | 0.040 |
Why?
|
RNA, Small Nuclear | 1 | 2020 | 25 | 0.040 |
Why?
|
Wakefulness | 2 | 2011 | 42 | 0.040 |
Why?
|
Catalytic Domain | 1 | 2021 | 193 | 0.040 |
Why?
|
Metabolic Networks and Pathways | 1 | 2021 | 74 | 0.040 |
Why?
|
NIH 3T3 Cells | 1 | 2020 | 95 | 0.040 |
Why?
|
Cysteine | 1 | 2021 | 107 | 0.040 |
Why?
|
Lysosomes | 1 | 2021 | 160 | 0.040 |
Why?
|
Forkhead Transcription Factors | 1 | 2020 | 125 | 0.040 |
Why?
|
Quantitative Trait Loci | 1 | 2020 | 70 | 0.040 |
Why?
|
Cell Cycle Proteins | 1 | 2022 | 384 | 0.040 |
Why?
|
Datasets as Topic | 1 | 2019 | 24 | 0.040 |
Why?
|
Cholesterol | 1 | 2021 | 252 | 0.040 |
Why?
|
Cancer Survivors | 1 | 2021 | 79 | 0.040 |
Why?
|
Fatty Acids | 1 | 2021 | 190 | 0.040 |
Why?
|
Stroop Test | 1 | 2019 | 7 | 0.040 |
Why?
|
Psychopathology | 1 | 2019 | 21 | 0.040 |
Why?
|
Membrane Glycoproteins | 1 | 2022 | 661 | 0.040 |
Why?
|
Ethanol | 1 | 2022 | 306 | 0.040 |
Why?
|
Functional Neuroimaging | 1 | 2019 | 14 | 0.040 |
Why?
|
Protein Transport | 1 | 2020 | 399 | 0.040 |
Why?
|
Megakaryocytes | 1 | 2018 | 18 | 0.040 |
Why?
|
Health Behavior | 1 | 2022 | 451 | 0.040 |
Why?
|
Automation | 1 | 2018 | 51 | 0.040 |
Why?
|
Lod Score | 2 | 2008 | 23 | 0.040 |
Why?
|
Pilot Projects | 1 | 2002 | 914 | 0.040 |
Why?
|
Connectome | 1 | 2018 | 29 | 0.040 |
Why?
|
Receptors, Cell Surface | 1 | 2021 | 428 | 0.040 |
Why?
|
Molecular Sequence Data | 2 | 2015 | 1952 | 0.040 |
Why?
|
Nuclear Proteins | 1 | 2022 | 750 | 0.040 |
Why?
|
CpG Islands | 1 | 2019 | 211 | 0.040 |
Why?
|
Multifactorial Inheritance | 1 | 2018 | 22 | 0.040 |
Why?
|
Cytoskeleton | 1 | 2018 | 137 | 0.040 |
Why?
|
Inflammation | 1 | 2024 | 1099 | 0.040 |
Why?
|
Health Promotion | 1 | 2022 | 471 | 0.040 |
Why?
|
Gene Expression | 2 | 2012 | 809 | 0.040 |
Why?
|
Blood Platelets | 1 | 2018 | 92 | 0.040 |
Why?
|
Genomics | 1 | 2020 | 319 | 0.040 |
Why?
|
Chromosomes, Human, Pair 4 | 2 | 2008 | 15 | 0.040 |
Why?
|
Lipoproteins | 1 | 2018 | 80 | 0.040 |
Why?
|
Biomarkers, Tumor | 1 | 2021 | 461 | 0.040 |
Why?
|
Treatment Outcome | 3 | 2015 | 5284 | 0.030 |
Why?
|
China | 2 | 2008 | 134 | 0.030 |
Why?
|
Culture | 1 | 2017 | 73 | 0.030 |
Why?
|
Psychomotor Performance | 2 | 2011 | 133 | 0.030 |
Why?
|
Cell Nucleus | 1 | 2020 | 608 | 0.030 |
Why?
|
Cell Line | 1 | 2021 | 1984 | 0.030 |
Why?
|
Models, Theoretical | 1 | 2018 | 256 | 0.030 |
Why?
|
Pregnancy | 1 | 2023 | 2202 | 0.030 |
Why?
|
Chi-Square Distribution | 2 | 2010 | 409 | 0.030 |
Why?
|
Epigenesis, Genetic | 1 | 2019 | 357 | 0.030 |
Why?
|
Gene Expression Regulation | 1 | 2022 | 1552 | 0.030 |
Why?
|
Waist Circumference | 1 | 2015 | 45 | 0.030 |
Why?
|
Fasting | 1 | 2015 | 48 | 0.030 |
Why?
|
Cholesterol, HDL | 1 | 2015 | 71 | 0.030 |
Why?
|
E2F3 Transcription Factor | 1 | 2015 | 1 | 0.030 |
Why?
|
Global Health | 1 | 2016 | 167 | 0.030 |
Why?
|
SOXC Transcription Factors | 1 | 2015 | 9 | 0.030 |
Why?
|
tRNA Methyltransferases | 1 | 2015 | 8 | 0.030 |
Why?
|
Cyclin-Dependent Kinase 5 | 1 | 2015 | 9 | 0.030 |
Why?
|
Acetyltransferases | 1 | 2015 | 24 | 0.030 |
Why?
|
Residence Characteristics | 1 | 2016 | 215 | 0.030 |
Why?
|
Reproducibility of Results | 2 | 2012 | 1561 | 0.030 |
Why?
|
Socioeconomic Factors | 1 | 2017 | 741 | 0.030 |
Why?
|
Sensitivity and Specificity | 1 | 2018 | 1093 | 0.030 |
Why?
|
RNA, Messenger | 1 | 2020 | 1465 | 0.030 |
Why?
|
Real-Time Polymerase Chain Reaction | 1 | 2015 | 191 | 0.030 |
Why?
|
Occupations | 1 | 2014 | 51 | 0.030 |
Why?
|
Heredity | 1 | 2014 | 6 | 0.030 |
Why?
|
Triglycerides | 1 | 2015 | 231 | 0.030 |
Why?
|
Cells, Cultured | 1 | 2018 | 2093 | 0.030 |
Why?
|
Nonlinear Dynamics | 1 | 2014 | 24 | 0.030 |
Why?
|
Endophenotypes | 1 | 2013 | 8 | 0.030 |
Why?
|
Neocortex | 1 | 2013 | 15 | 0.030 |
Why?
|
Genetics, Medical | 1 | 2013 | 11 | 0.030 |
Why?
|
Sequence Analysis, DNA | 1 | 2015 | 394 | 0.030 |
Why?
|
Survival Analysis | 2 | 2005 | 555 | 0.030 |
Why?
|
Cultural Deprivation | 1 | 2013 | 1 | 0.030 |
Why?
|
Learning | 1 | 2015 | 169 | 0.030 |
Why?
|
Lipids | 1 | 2015 | 300 | 0.030 |
Why?
|
Blood Glucose | 1 | 2015 | 461 | 0.030 |
Why?
|
Lipoproteins, HDL | 1 | 2013 | 35 | 0.030 |
Why?
|
International Agencies | 1 | 2012 | 7 | 0.030 |
Why?
|
Imaging, Three-Dimensional | 1 | 2015 | 275 | 0.030 |
Why?
|
Genes, X-Linked | 1 | 2012 | 19 | 0.030 |
Why?
|
Population Surveillance | 1 | 2014 | 194 | 0.030 |
Why?
|
Loneliness | 1 | 2012 | 18 | 0.030 |
Why?
|
Observer Variation | 1 | 2013 | 205 | 0.030 |
Why?
|
Base Sequence | 1 | 2015 | 1302 | 0.030 |
Why?
|
Drug Therapy, Combination | 1 | 2014 | 452 | 0.030 |
Why?
|
Signal Transduction | 1 | 2022 | 2902 | 0.030 |
Why?
|
Computer Simulation | 1 | 2015 | 458 | 0.030 |
Why?
|
Meta-Analysis as Topic | 1 | 2012 | 77 | 0.020 |
Why?
|
Respiratory Function Tests | 1 | 2013 | 189 | 0.020 |
Why?
|
Insulin Resistance | 1 | 2015 | 392 | 0.020 |
Why?
|
Personality | 1 | 2012 | 25 | 0.020 |
Why?
|
Insulin | 1 | 2015 | 674 | 0.020 |
Why?
|
Ear | 1 | 2011 | 9 | 0.020 |
Why?
|
Hypoparathyroidism | 1 | 2011 | 7 | 0.020 |
Why?
|
Eye Abnormalities | 1 | 2011 | 20 | 0.020 |
Why?
|
Immune System Diseases | 1 | 2011 | 17 | 0.020 |
Why?
|
Nose | 1 | 2011 | 28 | 0.020 |
Why?
|
Osmolar Concentration | 1 | 2011 | 88 | 0.020 |
Why?
|
Marriage | 1 | 2011 | 23 | 0.020 |
Why?
|
Japan | 1 | 2010 | 51 | 0.020 |
Why?
|
Social Identification | 1 | 2010 | 15 | 0.020 |
Why?
|
Social Perception | 1 | 2010 | 38 | 0.020 |
Why?
|
Heart Defects, Congenital | 1 | 2011 | 94 | 0.020 |
Why?
|
Aggression | 1 | 2010 | 52 | 0.020 |
Why?
|
Radioimmunoassay | 1 | 2010 | 63 | 0.020 |
Why?
|
Sample Size | 1 | 2010 | 61 | 0.020 |
Why?
|
Membrane Proteins | 1 | 2015 | 850 | 0.020 |
Why?
|
Quality Control | 1 | 2009 | 71 | 0.020 |
Why?
|
Lung | 1 | 2014 | 919 | 0.020 |
Why?
|
Affect | 1 | 2010 | 123 | 0.020 |
Why?
|
Chromosomes, Human, Pair 7 | 1 | 2008 | 12 | 0.020 |
Why?
|
Genetic Heterogeneity | 1 | 2008 | 21 | 0.020 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2010 | 168 | 0.020 |
Why?
|
Genetics, Population | 1 | 2008 | 40 | 0.020 |
Why?
|
Chromosomes, Human | 1 | 2008 | 53 | 0.020 |
Why?
|
Gene Frequency | 1 | 2008 | 118 | 0.020 |
Why?
|
Chilblains | 1 | 2007 | 1 | 0.020 |
Why?
|
Lymphocytosis | 1 | 2007 | 3 | 0.020 |
Why?
|
Ribonuclease H | 1 | 2007 | 18 | 0.020 |
Why?
|
Exodeoxyribonucleases | 1 | 2007 | 28 | 0.020 |
Why?
|
Likelihood Functions | 1 | 2007 | 68 | 0.020 |
Why?
|
Interview, Psychological | 1 | 2007 | 73 | 0.020 |
Why?
|
DNA Mutational Analysis | 1 | 2007 | 188 | 0.020 |
Why?
|
Calcinosis | 1 | 2007 | 79 | 0.020 |
Why?
|
Visual Acuity | 1 | 2007 | 117 | 0.020 |
Why?
|
Military Medicine | 1 | 2006 | 11 | 0.020 |
Why?
|
Incidence | 1 | 2010 | 1237 | 0.020 |
Why?
|
Phosphoproteins | 1 | 2007 | 211 | 0.020 |
Why?
|
Paranoid Disorders | 1 | 2005 | 2 | 0.020 |
Why?
|
Creativity | 1 | 2005 | 13 | 0.020 |
Why?
|
Intention | 1 | 2006 | 64 | 0.020 |
Why?
|
Confusion | 1 | 2005 | 16 | 0.020 |
Why?
|
Dyspepsia | 1 | 2005 | 1 | 0.020 |
Why?
|
Fatigue Syndrome, Chronic | 1 | 2005 | 9 | 0.020 |
Why?
|
Fibromyalgia | 1 | 2005 | 16 | 0.020 |
Why?
|
Peripheral Nervous System Diseases | 1 | 2005 | 26 | 0.020 |
Why?
|
Bias | 1 | 2005 | 108 | 0.010 |
Why?
|
In Situ Hybridization | 1 | 2005 | 214 | 0.010 |
Why?
|
Skin Diseases | 1 | 2005 | 76 | 0.010 |
Why?
|
Antigens, Viral | 1 | 2005 | 130 | 0.010 |
Why?
|
Myocardial Infarction | 1 | 2010 | 862 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2005 | 847 | 0.010 |
Why?
|
Treatment Failure | 1 | 2003 | 185 | 0.010 |
Why?
|
Interviews as Topic | 1 | 2004 | 481 | 0.010 |
Why?
|
Asia, Southeastern | 1 | 2002 | 5 | 0.010 |
Why?
|
DNA | 1 | 2007 | 806 | 0.010 |
Why?
|
Affective Symptoms | 1 | 2002 | 15 | 0.010 |
Why?
|
Mental Health Services | 1 | 2002 | 268 | 0.010 |
Why?
|
Hospitalization | 1 | 2002 | 1290 | 0.010 |
Why?
|